Bnp Paribas Asset Management Holding S.A. Legend Biotech Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Legend Biotech Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 14,043 shares of LEGN stock, worth $451,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,043
Previous 14,392
2.42%
Holding current value
$451,061
Previous $488,000
2.05%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
238Shares Held
59.7MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$222 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$192 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$184 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$121 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$95.2 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...